JPRN-UMIN000028922招募中未知
Pharmacokinetic study of osimertinib in NSCLC patients with body fluid - Pharmacokinetic study of osimertinib in NSCLC patients with body fluid
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with interstitial pneumonitis identified by chest X-ray
研究者
相似试验
已完成
不适用
A Phase 2 Study of Osimertinib for Advanced NSCLC with Malignant Pleural Effusion Harboring EGFR T790M mutationon-small cell lung cancerJPRN-UMIN000026669The Japan-Multinational Trial Organization25
进行中（未招募）
1 期
Study to osimertinib treatment in patients with lung cancer.on-small cell lung carcinomaEUCTR2018-004290-28-NL20
已完成
不适用
Pharmacokinetic boosting of osimertinib in patients with non-small cell lung cancer.lung cancerNL-OMON55742Medisch Universitair Ziekenhuis Maastricht29
已完成
不适用
An Evaluation of tumor response to osimertinib by early FDG-PET finding in patients with T790M positive EGFR mutated non-small cell lung cancerT790M (detected by cobas EGFR Mutation Test v2) from the relapsed tumor after EGFR-TKI therapy.JPRN-UMIN000027550Department of Comprehensive Cancer Therapy, Shinshu University School of Medicine, 3-1-1, Asahi Matsumoto, 390-8621, Japan,30
已完成
不适用
Observational study of osimertinib for patients with locally advanced/metastatic non-small cell lung cancer who are harboring T790M mutation detected by liquid biopsy and whose disease has progressed with previous EGFR-TKI therapy(WJOG8815LFS)EGFR mutation positive advanced or metastatic NSCLCJPRN-UMIN000034682West Japan Oncology Group33